BONE REGENERATION AROUND DENTAL IMPLANTS WITH LOCAL ADMINISTRATION OF BISPHOSPHONATES

局部使用双膦酸盐促进牙种植体周围的骨再生

基本信息

  • 批准号:
    15592065
  • 负责人:
  • 金额:
    $ 2.05万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2005
  • 项目状态:
    已结题

项目摘要

Bisphosphonates (Bps) have been used as an effective drug for patients suffer from osteoporosis. The Bps chemically binds to the calcium phosphate in the bone and suppresses the activation of osteoclasts. In addition, Bps is known to inhibit bone resorption by directly facilitating osteoclast apoptosis.It was revealed that the Bps chemically binds to the hydroxyapatite (HAp) by FT-IR analysis. The efficacy of hydroxyapatite (HAp) as a carrier was investigated in order to establish a method of local administration of bisphosphonates (Bps), which has currently been administered systemically. HAp granules 300-500 μm in size were prepared with different physicochemical features by altering the sintering temperature. To ascertain the physicochemical properties of the HAp granules, their crystallinity was assessed using X-ray diffraction, the surface morphology was examined under scanning electron microscopy, and the specific surface area and calcium dissolution were evaluated. Different Bps-HAp composites were subsequently prepared and the concentration of Bps released from these composites was measured. The influence of Bps-HAp composites on the rate of osteoclast survival was also evaluated. The results revealed that 1) HAp solubility depends on the sintering temperature ; 2) The concentration of released Bps could be controlled by regulating the sintering temperature of HAp as a carrier ; and 3) Bps released from Bps-HAp composites reduced the number of osteoclasts. These findings indicated that Bps-HAp composites could be locally administered as a drug delivery system to areas with bone resorption.Furthermore, the molecular precursor solution was prepared by the addition of dibutylammonium metaphosphate salt into the ethanol solution of Ca-EDTA/amine complex to establish the titanium-HAp scaffold with DDS. Carbonate-containing hydroxyapatite was deposited onto titanium scaffold using molecular precursor method, which was novel technique for coating metal oxide film.
双膦酸盐(Bps)已被用作治疗骨质疏松症患者的有效药物。 Bps 与骨中的磷酸钙发生化学结合,抑制破骨细胞的活化。此外,已知 Bps 可通过直接促进破骨细胞凋亡来抑制骨吸收。通过 FT-IR 分析表明,Bps 与羟基磷灰石 (HAp) 发生化学结合。研究羟基磷灰石(HAp)作为载体的功效,以建立目前已全身给药的双膦酸盐(Bps)的局部给药方法。通过改变烧结温度,制备出具有不同理化特性的300-500 μm尺寸的HAp颗粒。为了确定 HAp 颗粒的物理化学性质,使用 X 射线衍射评估了它们的结晶度,在扫描电子显微镜下检查了表面形态,并评估了比表面积和钙溶解度。随后制备了不同的 Bps-HAp 复合材料,并测量了从这些复合材料中释放的 Bps 浓度。还评估了 Bps-HAp 复合材料对破骨细胞存活率的影响。结果表明:1)HAp溶解度取决于烧结温度; 2)通过调节HAp作为载体的烧结温度可以控制释放的Bps浓度; 3) Bps-HAp 复合材料释放的 Bps 减少了破骨细胞的数量。这些结果表明,Bps-HAp复合材料可以作为药物递送系统局部给药至骨吸收区域。此外,通过将偏磷酸二丁基铵盐添加到Ca-EDTA/胺复合物的乙醇溶液中来制备分子前体溶液,以用DDS建立钛-HAp支架。采用分子前驱体法将含碳酸盐的羟基磷灰石沉积在钛支架上,这是一种涂覆金属氧化物薄膜的新技术。

项目成果

期刊论文数量(90)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Molecular precursor method for thin calcium phosphate coating on titanium
钛表面磷酸钙薄膜的分子前体法
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Takahashi K;Hayakawa T;Yoshinari M;Hara H;Mochizuki C;Sato M;Nemoto K
  • 通讯作者:
    Nemoto K
Matsuzaka K, Yoshinari M, Shimono M, Inoue T: "Effects of multi-grooved surfaces on osteoblast-like cells in vitro : Scanning electron microscopic observation and mRNA expression of ostopontin and osteocalcin"J Biomed Mater Res. 68A. 227-234 (2004)
Matsuzaka K,Yoshinari M,Shimono M,Inoue T:“多凹槽表面对体外成骨细胞样细胞的影响:扫描电子显微镜观察和骨桥蛋白和骨钙素的 mRNA 表达”J Biomed Mater Res。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effects of multi-grooved surfaces on osteoblast-like cells in vitro : Scanning electron microscopic observation and mRNA expression of ostopontin an osteocalcin
多孔表面对体外成骨样细胞的影响:扫描电镜观察和骨桥蛋白和骨钙素的mRNA表达
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Matsuzaka K;Yoshinari M;Shimono M;Inoue T.
  • 通讯作者:
    Inoue T.
平成15年度産業化を目指す健康医療メカトロニクスの新技術シーズと社会ニーズに関する調査研究報告
2003年面向产业化的健康医疗机电一体化新技术种子及社会需求研究报告
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Seshima H;Yoshinari M;Takemoto S;Hattori M;Kawada E;Inoue T;Oda Y;吉成正雄(分担執筆);吉成正雄(分担執筆);山根隆志;吉成正雄(分担執筆)
  • 通讯作者:
    吉成正雄(分担執筆)
Effects of multigrooved surfaces on fibroblast behavior.
  • DOI:
    10.1002/jbm.a.10521
  • 发表时间:
    2003-06
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Yoshinari;K. Matsuzaka;T. Inoue;Y. Oda;M. Shimono
  • 通讯作者:
    M. Yoshinari;K. Matsuzaka;T. Inoue;Y. Oda;M. Shimono
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YOSHINARI Masao其他文献

Comparison of retentive forces between telescopic crowns made of poly(ether ether ketone) and type 4 gold alloy
聚醚醚酮伸缩冠与4型金合金冠固位力比较
  • DOI:
    10.4012/dmj.2019-298
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    NAKAMURA Mikayo;TANAKA Akihiro;TASAKA Akinori;YOSHINARI Masao;TAKEMOTO Shinji;YAMASHITA Shuichiro
  • 通讯作者:
    YAMASHITA Shuichiro

YOSHINARI Masao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YOSHINARI Masao', 18)}}的其他基金

Development of novel implants with local administration of fluvastatin-gelatin complex
开发局部施用氟伐他汀-明胶复合物的新型植入物
  • 批准号:
    24390446
  • 财政年份:
    2012
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Evaluation of mechanical property by preferential alignment of biological apatite in human mandible
通过生物磷灰石在人下颌骨中优先排列的机械性能评价
  • 批准号:
    23659925
  • 财政年份:
    2011
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of immediate implant system with biofunctionalization using drug delivery system
使用药物输送系统开发具有生物功能化的即刻种植系统
  • 批准号:
    18390524
  • 财政年份:
    2006
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
DEVELOPMENT OF DENTAL IMPLANTS FOR IMPROVING OSTEOPOROSIS -ENHANCEMENT OF OSTEOGENISIS BY SURFACE MODIFICATION-
开发用于改善骨质疏松症的牙种植体 -通过表面修饰增强成骨作用 -
  • 批准号:
    10671845
  • 财政年份:
    1998
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Titanium Surface Modification with Ion Beam Mixing Method for Implant Use -Influence of Solubility of Thin Calcium-phosphate Coatings on Cell Behavior-
植入用离子束混合法钛表面改性-磷酸钙薄涂层溶解度对细胞行为的影响-
  • 批准号:
    07672123
  • 财政年份:
    1995
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Renewed bone remodeling after pausing long-term bisphosphonate use: Does it replace regions of impaired bone quality and restore mechanical integrity?
暂停长期使用双膦酸盐后重新进行骨重塑:它是否可以替代骨质量受损的区域并恢复机械完整性?
  • 批准号:
    10656954
  • 财政年份:
    2023
  • 资助金额:
    $ 2.05万
  • 项目类别:
Pooling International Cohort Studies of Long-Term Bisphosphonate Use and Atypical Femur Fractures
长期使用双膦酸盐和非典型股骨骨折的汇集国际队列研究
  • 批准号:
    10516684
  • 财政年份:
    2022
  • 资助金额:
    $ 2.05万
  • 项目类别:
Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery
使用双膦酸盐减轻减肥手术继发的骨质流失
  • 批准号:
    10440068
  • 财政年份:
    2022
  • 资助金额:
    $ 2.05万
  • 项目类别:
Exercise and Bisphosphonate Use to Minimize Weight Loss Associated Bone Loss among Older Adults
运动和双磷酸盐的使用可最大限度地减少老年人与体重减轻相关的骨质流失
  • 批准号:
    10517723
  • 财政年份:
    2022
  • 资助金额:
    $ 2.05万
  • 项目类别:
Pooling International Cohort Studies of Long-Term Bisphosphonate Use and Atypical Femur Fractures
长期使用双膦酸盐和非典型股骨骨折的汇集国际队列研究
  • 批准号:
    10706659
  • 财政年份:
    2022
  • 资助金额:
    $ 2.05万
  • 项目类别:
Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery
使用双膦酸盐减轻减肥手术继发的骨质流失
  • 批准号:
    10624846
  • 财政年份:
    2022
  • 资助金额:
    $ 2.05万
  • 项目类别:
Novel Bisphosphonate PET Probes for Myeloma Bone Disease
用于骨髓瘤骨病的新型双膦酸盐 PET 探针
  • 批准号:
    10405086
  • 财政年份:
    2021
  • 资助金额:
    $ 2.05万
  • 项目类别:
Novel Bisphosphonate PET Probes for Myeloma Bone Disease
用于骨髓瘤骨病的新型双膦酸盐 PET 探针
  • 批准号:
    10616547
  • 财政年份:
    2021
  • 资助金额:
    $ 2.05万
  • 项目类别:
IMAT‐ITCR Collaboration: Preclinical Evaluation of Novel Bisphosphonate PET Probes for Myeloma Bone Disease
IMAT-ITCR 合作:新型双膦酸盐 PET 探针治疗骨髓瘤骨病的临床前评估
  • 批准号:
    10461625
  • 财政年份:
    2021
  • 资助金额:
    $ 2.05万
  • 项目类别:
Regulation of bisphosphonate-related osteonecrosis by M2 macrophage differentiation via Nrf2 activation
通过 Nrf2 激活 M2 巨噬细胞分化调节双磷酸盐相关的骨坏死
  • 批准号:
    21K10199
  • 财政年份:
    2021
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了